Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-small Cell Lung Cancer Metastatic 1

Interventions

Carboplatin 1176 Cisplatin 893 Pemetrexed 849 pembrolizumab 627 Paclitaxel 610 Docetaxel 539 Gemcitabine 428 Radiotherapy 393 Erlotinib Hydrochloride 381 Nivolumab 344 Bevacizumab 337 Etoposide 297 durvalumab 265 Drug Therapy 260 osimertinib 237 atezolizumab 225 Radiosurgery 196 Gefitinib 186 Vinorelbine 149 Magnetic Resonance Spectroscopy 132 Ipilimumab 129 130-nm albumin-bound paclitaxel 125 Cetuximab 113 anlotinib 106 Blood Specimen Collection 106 tislelizumab 104 Topotecan 103 Specimen Handling 102 Surgical Procedures, Operative 101 Cyclophosphamide 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

GC Temporary Stopping × Thoracic × Clear all

NCT06127940 2023-11-13

K-SAB

Karolinska University Hospital

Phase 1 Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡